» Articles » PMID: 8579905

The Insulin-like Growth Factor System and the Coupling of Formation to Resorption

Overview
Journal Bone
Date 1995 Aug 1
PMID 8579905
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

In the adult skeleton, bone formation is regulated by an event referred to as the coupling of formation to resorption (i.e., formation is linked to resorption), which is thought to be mediated in part by locally produced growth factors. Although human bone cells produce and human bones contain a variety of growth factors, there is sufficient evidence to document an important role for the insulin-like growth factor (IGF) system in mediating this coupling process in bone. Studies on the basic aspects of the IGF system in bone reveal that it is complex and involves a number of components which include the IGF-binding proteins (IGFBPs; mainly IGFBP-3, -4, and -5), specific extracellular IGFBP proteases, and receptors (types 1 and 2). Based on recent experimental evidence from a number of laboratories, we propose the following models of IGF action on the regulation of the coupled increase in bone formation in response to bone resorption: (1) IGF release from bone during bone resorption promotes osteoblasts to initiate cavity refilling; (2) IGF production by osteoclasts creates a population of osteoblasts in proportion to the volume of bone tissue resorbed; and (3) IGF production by stromal cells and osteoblasts predominantly regulates the extent of cavity refill. The amount of growth factor production by osteoblasts and contemporary cells of osteoblast lineage can be further controlled by both systemic and local factors which together determine the eventual level of fill-in of the resorption cavity.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Sex-Specific Effects of THRβ Signaling on Metabolic Responses to High Fat Diet in Mice.

Muralidharan A, Gomez G, Kesavan C, Pourteymoor S, Larkin D, Tambunan W Endocrinology. 2024; 165(8).

PMID: 38935021 PMC: 11237353. DOI: 10.1210/endocr/bqae075.


The IL-17-IL-17RA axis is required to promote osteosarcoma progression in mice.

Yoshimura N, Kariya R, Shimada M, Tateyama M, Matsunaga H, Shibata Y Sci Rep. 2023; 13(1):21572.

PMID: 38062130 PMC: 10703823. DOI: 10.1038/s41598-023-49016-1.


Targeting strategies for bone diseases: signaling pathways and clinical studies.

Xu H, Wang W, Liu X, Huang W, Zhu C, Xu Y Signal Transduct Target Ther. 2023; 8(1):202.

PMID: 37198232 PMC: 10192458. DOI: 10.1038/s41392-023-01467-8.


CD301b macrophage: the new booster for activating bone regeneration in periodontitis treatment.

Wang C, Zhao Q, Chen C, Li J, Zhang J, Qu S Int J Oral Sci. 2023; 15(1):19.

PMID: 37198150 PMC: 10192316. DOI: 10.1038/s41368-023-00225-4.


Notch Signaling in the Bone Marrow Lymphopoietic Niche.

Sottoriva K, Pajcini K Front Immunol. 2021; 12:723055.

PMID: 34394130 PMC: 8355626. DOI: 10.3389/fimmu.2021.723055.